Such a disparity is observed because clock and clock-regulated genes in tumour cells frequently have different circadian profiles (either shifted or completely disrupted), or even different period lengths,49, 50, 51, 52 which allows to choose the optimal time at which the drug is more cytotoxic for tumour cells, as compared to the healthy cells in the organism. Here, CLOCK is linked to neoplasm.